Literature DB >> 33972671

Mucosal ribosomal stress-induced PRDM1 promotes chemoresistance via stemness regulation.

Juil Kim1, Yuseok Moon2,3.   

Abstract

The majorities of colorectal cancer (CRC) cases are sporadic in origin and a large proportion of etiologies are associated with environmental stress responses. In response to external and internal stress, the ribosome stands sentinel and stress-driven ribosomal dysfunction triggers the cellular decision pathways via transcriptional reprogramming. In the present study, PR domain zinc finger protein (PRDM) 1, a master transcriptional regulator, was found to be closely associated with ribosomal actions in patients with CRC and the murine models. Stress-driven ribosomal dysfunction enhanced PRDM1 levels in intestinal cancer cells, which contributed to their survival and enhanced cancer cell stemness against cancer treatment. Mechanistically, PRDM1 facilitated clustering modulation of insulin-like growth factor (IGF) receptor-associated genes, which supported cancer cell growth and stemness-linked features. Ribosomal dysfunction-responsive PRDM1 facilitated signaling remodeling for the survival of tumor progenitors, providing compelling evidence for the progression of sporadic CRC.

Entities:  

Year:  2021        PMID: 33972671     DOI: 10.1038/s42003-021-02078-1

Source DB:  PubMed          Journal:  Commun Biol        ISSN: 2399-3642


  54 in total

1.  Blimp-1 orchestrates plasma cell differentiation by extinguishing the mature B cell gene expression program.

Authors:  A L Shaffer; Kuo I Lin; Tracy C Kuo; Xin Yu; Elaine M Hurt; Andreas Rosenwald; Jena M Giltnane; Liming Yang; Hong Zhao; Kathryn Calame; Louis M Staudt
Journal:  Immunity       Date:  2002-07       Impact factor: 31.745

Review 2.  Blimp1: driving terminal differentiation to a T.

Authors:  Annie Xin; Stephen L Nutt; Gabrielle T Belz; Axel Kallies
Journal:  Adv Exp Med Biol       Date:  2011       Impact factor: 2.622

3.  Transcriptional repression by blimp-1 (PRDI-BF1) involves recruitment of histone deacetylase.

Authors:  J Yu; C Angelin-Duclos; J Greenwood; J Liao; K Calame
Journal:  Mol Cell Biol       Date:  2000-04       Impact factor: 4.272

4.  B lymphocyte-induced maturation protein (Blimp)-1, IFN regulatory factor (IRF)-1, and IRF-2 can bind to the same regulatory sites.

Authors:  Tracy C Kuo; Kathryn L Calame
Journal:  J Immunol       Date:  2004-11-01       Impact factor: 5.422

Review 5.  An expanding job description for Blimp-1/PRDM1.

Authors:  Elizabeth K Bikoff; Marc A Morgan; Elizabeth J Robertson
Journal:  Curr Opin Genet Dev       Date:  2009-07-09       Impact factor: 5.578

6.  Loss of PRDM1/BLIMP-1 function contributes to poor prognosis of activated B-cell-like diffuse large B-cell lymphoma.

Authors:  Y Xia; Z Y Xu-Monette; A Tzankov; X Li; G C Manyam; V Murty; G Bhagat; S Zhang; L Pasqualucci; C Visco; K Dybkaer; A Chiu; A Orazi; Y Zu; K L Richards; E D Hsi; W W L Choi; J H van Krieken; J Huh; M Ponzoni; A J M Ferreri; M B Møller; B M Parsons; J N Winter; M A Piris; J Westin; N Fowler; R N Miranda; C Y Ok; Y Li; J Li; L J Medeiros; K H Young
Journal:  Leukemia       Date:  2016-08-29       Impact factor: 11.528

7.  PRDI-BF1/Blimp-1 repression is mediated by corepressors of the Groucho family of proteins.

Authors:  B Ren; K J Chee; T H Kim; T Maniatis
Journal:  Genes Dev       Date:  1999-01-01       Impact factor: 11.361

8.  Identification and characterization of a novel repressor of beta-interferon gene expression.

Authors:  A D Keller; T Maniatis
Journal:  Genes Dev       Date:  1991-05       Impact factor: 11.361

9.  High expression of PRDM14 correlates with cell differentiation and is a novel prognostic marker in resected non-small cell lung cancer.

Authors:  Tiehong Zhang; Long Meng; Wei Dong; Hongchang Shen; Shuming Zhang; Qi Liu; Jiajun Du
Journal:  Med Oncol       Date:  2013-05-21       Impact factor: 3.064

10.  PRDI-BF1 recruits the histone H3 methyltransferase G9a in transcriptional silencing.

Authors:  Ildikó Gyory; Jian Wu; György Fejér; Edward Seto; Kenneth L Wright
Journal:  Nat Immunol       Date:  2004-02-22       Impact factor: 25.606

View more
  1 in total

Review 1.  Insulin-like growth factor-1 signaling in the tumor microenvironment: Carcinogenesis, cancer drug resistance, and therapeutic potential.

Authors:  Armel H Nwabo Kamdje; Paul F Seke Etet; Maulilio J Kipanyula; Lorella Vecchio; Richard Tagne Simo; Alfred K Njamnshi; Kiven E Lukong; Patrice N Mimche
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-09       Impact factor: 6.055

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.